This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment [Yahoo! Finance]
EyePoint, Inc. (EYPT)
Last eyepoint, inc. earnings: 3/5 07:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
On February 17, 2026, Parkman Healthcare Partners disclosed a new position in EyePoint (NASDAQ:EYPT) , acquiring 1,088,033 shares in the fourth quarter. What happened According to a Securities and Exchange Commission (SEC) filing dated February 17, 2026, Parkman Healthcare Partners established a new stake in EyePoint by purchasing 1,088,033 shares during the fourth quarter. The quarter-end value of the position increased by $19.88 million as a result of the acquisition. What else to know This was a new position; EyePoint represented 1.89% of Parkman's 13F reportable AUM as of December 31, 2025. Top holdings after the filing: NYSE: BSX: $47.73 million (4.5% of AUM) NASDAQ: PODD: $40.04 million (3.8% of AUM) NASDAQ: DXCM: $38.99 million (3.7% of AUM) NYSE: SYK: $37.07 million (3.5% of AUM) NYSE: CVS: $35.73 million (3.4% of AUM) As of Friday, EyePoint shares were priced at $13.20, up a staggering 93% over the past year and well outperforming the S&P 500's roughly
Show less
Read more
Impact Snapshot
Event Time:
EYPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EYPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EYPT alerts
High impacting EyePoint, Inc. news events
Weekly update
A roundup of the hottest topics
EYPT
News
- EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswire
- Eyepoint Pharmaceuticals (EYPT) had its price target raised by Citigroup Inc. from $31.00 to $35.00. They now have a "buy" rating on the stock.MarketBeat
- Eyepoint Pharmaceuticals (EYPT) had its price target raised by HC Wainwright from $23.00 to $30.00. They now have a "buy" rating on the stock.MarketBeat
- EyePoint Inc (EYPT) Q4 2025 Earnings Call Highlights: Navigating Revenue Decline Amid Promising ... [Yahoo! Finance]Yahoo! Finance
- Eyepoint Pharmaceuticals (EYPT) had its price target raised by Chardan Capital from $27.00 to $29.00. They now have a "buy" rating on the stock.MarketBeat
EYPT
Earnings
- 3/4/26 - Miss
EYPT
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/24/26 - Form 4
- 3/20/26 - Form 8-K
- EYPT's page on the SEC website